Phenibut Hydrochloride has carved a significant niche for itself within the realm of pharmaceutical intermediates and research chemicals. Its identity as a derivative of GABA, coupled with its ability to cross the blood-brain barrier, makes it a compound of interest for scientific exploration and potential drug development pathways. Understanding its role as a 'pharmaceutical intermediate' is key to appreciating its value in the broader chemical supply chain.

As a 'pharmaceutical intermediate', Phenibut Hydrochloride is not typically a final product but a crucial building block or reference compound used in the development and testing of new pharmaceuticals, particularly those targeting the central nervous system. The demand for high-purity Phenibut Hydrochloride, often available as a 'phenibut hydrochloride powder', fuels a market where reliable suppliers are essential. When seeking to 'buy phenibut hydrochloride powder', researchers often look for companies that can guarantee stringent quality control and provide comprehensive documentation, such as Certificates of Analysis (COA), confirming its purity and conformity to standards.

The 'phenibut hydrochloride powder chemical properties' discussed previously, such as its appearance, melting point, and solubility, are critical parameters for its use as an intermediate. These properties dictate how it can be processed and incorporated into larger molecular structures or experimental formulations. The market for Phenibut Hydrochloride is also influenced by its 'phenibut hydrochloride powder legal status' and varying regulatory landscapes, which can affect availability and pricing. Discussions around 'phenibut hydrochloride powder pricing' often consider factors like purity, quantity, and the supplier's reputation.

Furthermore, the compound's pharmacological profile, particularly its interaction with GABAB receptors and its potential 'anxiolytic effects', makes it a valuable tool for studying neurological disorders and testing potential therapeutic agents. The availability of 'phenibut hydrochloride powder for anxiety' research highlights its relevance in understanding and potentially treating anxiety-related conditions. Researchers often compare its effects and properties to other GABA analogues, contributing to a broader understanding of GABAA and GABAB receptor modulation.

In summary, Phenibut Hydrochloride's position as a pharmaceutical intermediate and a subject of intense research underscores its importance in the chemical and scientific communities. For those looking to 'purchase phenibut hydrochloride powder', partnering with reputable 'suppliers' who adhere to high 'quality' standards is paramount to ensure the integrity and success of their research endeavors. The continued study of its 'phenibut hydrochloride powder chemical properties' and applications will undoubtedly contribute to advancements in neuroscience and pharmaceutical development.